RE: The A will be handed on a plate10 May 2022 14:21
Yeah agreed, price could be suppressed given the low liquidity and possible selling from Gavin. I imagine this will continue to be very volatile until substantial news from clinical trials come out. Despite the share price being hammered, I do think there is significant upside (clinical trials dependant). The scientist team are very capable and have a track record of bringing drugs to market and they are still within expected timeframes and cash burn.